SW-579 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Head-Neck cancer cell lines |
| Organism |
Human |
| Donor History |
Squamous cell carcinoma |
| Growth Properties |
Monolayer ,adherent |
| Growth Conditions |
Culture medium: RPMI 1640 ,w: 2.0 mM stable Glutamine ,w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
SW-579 is a human thyroid squamous cell carcinoma cell line, commonly used in cancer research to study thyroid cancer progression and invasiveness. This cell line has been particularly valuable in research exploring the role of matrix metalloproteinases (MMPs) and integrins in cancer cell invasion. Studies involving SW-579 have demonstrated that bone sialoprotein (BSP) significantly enhances the invasiveness of these cells by forming a trimolecular complex with MMP-2 and integrin αvβ3. This complex promotes cancer cell movement through extracellular matrices, mimicking the invasive behavior of metastatic cancers.
In vitro experiments using a modified Boyden chamber invasion assay have shown that treating SW-579 cells with BSP increased their invasiveness by approximately 10-fold compared to untreated controls. This enhanced invasiveness was found to be mediated by MMP-2 and integrin αvβ3, as blocking either the integrin or MMP-2 significantly reduced the effect. These findings highlight the critical role of MMPs and integrins in the metastatic potential of thyroid cancers, making SW-579 a useful model for studying targeted therapies aimed at disrupting these pathways.
Moreover, the involvement of BSP in SW-579 cell invasiveness suggests potential therapeutic targets for inhibiting metastasis in thyroid carcinoma. By interfering with the formation of the BSP-MMP-2-integrin αvβ3 complex, researchers may be able to reduce the invasiveness of these cancer cells, offering a promising approach to limiting the spread of thyroid cancer in patients.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

